Comment: Frequency of Serum Creatinine Monitoring During Allopurinol Therapy in Ambulatory Patients

Abstract

Get full access to this article

View all access options for this article.

References

Raebel

McClure

Simon

. Frequency of serum creatinine monitoring during allopurinol therapy in ambulatory patients. Ann Pharmacother 2006;40:386–91. Epub 14 Feb 2006. DOI 10.1345/aph.1G589

Conaghan

Day

. Risks and benefits of drugs used in the management and prevention of gout. Drug Saf 1994;11:252–8.

Hande

Noone

Stone

. Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency. Am J Med 1984;76:47–56.

Vazquez-Mellado

Morales

Pacheco-Tena

Burgos-Vargas

. Relation between adverse events associated with allopurinol and renal function in patients with gout. Ann Rheum Dis 2001;60:981–3.

Mikuls

MacLean

Olivieri

. Quality of care indicators for gout management. Arthritis Rheum 2004;50:937–43.